JP2021500070A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021500070A5 JP2021500070A5 JP2020542536A JP2020542536A JP2021500070A5 JP 2021500070 A5 JP2021500070 A5 JP 2021500070A5 JP 2020542536 A JP2020542536 A JP 2020542536A JP 2020542536 A JP2020542536 A JP 2020542536A JP 2021500070 A5 JP2021500070 A5 JP 2021500070A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- capsid protein
- protein corresponding
- aav
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001413 amino acids Chemical class 0.000 claims 202
- 108090000565 Capsid Proteins Proteins 0.000 claims 108
- 102100023321 Ceruloplasmin Human genes 0.000 claims 108
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 102
- 239000002773 nucleotide Substances 0.000 claims 43
- 125000003729 nucleotide group Chemical group 0.000 claims 43
- 238000000034 method Methods 0.000 claims 18
- 108090000623 proteins and genes Proteins 0.000 claims 17
- 108091026890 Coding region Proteins 0.000 claims 12
- 230000037430 deletion Effects 0.000 claims 11
- 238000012217 deletion Methods 0.000 claims 11
- 101150013707 HBB gene Proteins 0.000 claims 9
- 125000003275 alpha amino acid group Chemical group 0.000 claims 9
- 210000004027 cell Anatomy 0.000 claims 9
- 102100021519 Hemoglobin subunit beta Human genes 0.000 claims 8
- 101710163270 Nuclease Proteins 0.000 claims 8
- 101000899111 Homo sapiens Hemoglobin subunit beta Proteins 0.000 claims 7
- 230000002950 deficient Effects 0.000 claims 7
- 230000037431 insertion Effects 0.000 claims 7
- 238000003780 insertion Methods 0.000 claims 7
- 230000010076 replication Effects 0.000 claims 7
- 241000702421 Dependoparvovirus Species 0.000 claims 6
- 210000000234 capsid Anatomy 0.000 claims 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 6
- USWINTIHFQKJTR-UHFFFAOYSA-N 3-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C1=C(S(O)(=O)=O)C=C2C=C(S(O)(=O)=O)C(O)=CC2=C1 USWINTIHFQKJTR-UHFFFAOYSA-N 0.000 claims 5
- 238000010361 transduction Methods 0.000 claims 5
- 241000255925 Diptera Species 0.000 claims 4
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims 4
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims 4
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims 4
- 230000035772 mutation Effects 0.000 claims 4
- 210000000130 stem cell Anatomy 0.000 claims 4
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 3
- -1 SEQ ID NO: 2 amino acid Chemical class 0.000 claims 3
- 239000002253 acid Substances 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000035475 disorder Diseases 0.000 claims 3
- 238000004806 packaging method and process Methods 0.000 claims 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 3
- 102000004169 proteins and genes Human genes 0.000 claims 3
- 230000026683 transduction Effects 0.000 claims 3
- 206010064571 Gene mutation Diseases 0.000 claims 2
- 108091081024 Start codon Proteins 0.000 claims 2
- 238000011260 co-administration Methods 0.000 claims 2
- 210000000805 cytoplasm Anatomy 0.000 claims 2
- 210000003743 erythrocyte Anatomy 0.000 claims 2
- 238000000338 in vitro Methods 0.000 claims 2
- 230000010354 integration Effects 0.000 claims 2
- 210000001778 pluripotent stem cell Anatomy 0.000 claims 2
- MTJGVAJYTOXFJH-UHFFFAOYSA-N 3-aminonaphthalene-1,5-disulfonic acid Chemical group C1=CC=C(S(O)(=O)=O)C2=CC(N)=CC(S(O)(=O)=O)=C21 MTJGVAJYTOXFJH-UHFFFAOYSA-N 0.000 claims 1
- HBZVNWNSRNTWPS-UHFFFAOYSA-N 6-amino-4-hydroxynaphthalene-2-sulfonic acid Chemical compound C1=C(S(O)(=O)=O)C=C(O)C2=CC(N)=CC=C21 HBZVNWNSRNTWPS-UHFFFAOYSA-N 0.000 claims 1
- 108700028369 Alleles Proteins 0.000 claims 1
- 108020004705 Codon Proteins 0.000 claims 1
- 102100031780 Endonuclease Human genes 0.000 claims 1
- 108010042407 Endonucleases Proteins 0.000 claims 1
- 108700024394 Exon Proteins 0.000 claims 1
- 108091005904 Hemoglobin subunit beta Proteins 0.000 claims 1
- 101001000998 Homo sapiens Protein phosphatase 1 regulatory subunit 12C Proteins 0.000 claims 1
- 108700026244 Open Reading Frames Proteins 0.000 claims 1
- 102100035620 Protein phosphatase 1 regulatory subunit 12C Human genes 0.000 claims 1
- 108020005067 RNA Splice Sites Proteins 0.000 claims 1
- 208000002903 Thalassemia Diseases 0.000 claims 1
- 101150079678 hbb1 gene Proteins 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000008488 polyadenylation Effects 0.000 claims 1
- 208000007056 sickle cell anemia Diseases 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762574163P | 2017-10-18 | 2017-10-18 | |
| US62/574,163 | 2017-10-18 | ||
| US201862621102P | 2018-01-24 | 2018-01-24 | |
| US62/621,102 | 2018-01-24 | ||
| PCT/US2018/056271 WO2019079437A1 (en) | 2017-10-18 | 2018-10-17 | ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR RESTORING THE FUNCTION OF THE HBB GENE AND METHODS OF USE |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021500070A JP2021500070A (ja) | 2021-01-07 |
| JP2021500070A5 true JP2021500070A5 (enExample) | 2021-12-02 |
Family
ID=64332161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020542536A Pending JP2021500070A (ja) | 2017-10-18 | 2018-10-17 | Hbb遺伝子機能を回復させるためのアデノ随伴ウイルス組成物およびその使用方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12201657B2 (enExample) |
| EP (1) | EP3697450A1 (enExample) |
| JP (1) | JP2021500070A (enExample) |
| KR (1) | KR20200095462A (enExample) |
| CN (1) | CN111447954A (enExample) |
| AU (1) | AU2018352855B2 (enExample) |
| BR (1) | BR112020007765A2 (enExample) |
| CA (1) | CA3079437A1 (enExample) |
| IL (1) | IL273877A (enExample) |
| MX (1) | MX2020004092A (enExample) |
| SG (1) | SG11202002737PA (enExample) |
| WO (1) | WO2019079437A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109536494A (zh) * | 2017-10-31 | 2019-03-29 | 广东赤萌医疗科技有限公司 | 一种用于修复HBB1基因点突变的gRNA、基因编辑系统、表达载体和基因编辑试剂盒 |
| CA3166374A1 (en) * | 2019-12-31 | 2021-07-08 | Swanbio Therapeutics Limited | Improved aav-abcd1 constructs and use for treatment or prevention of adrenoleukodystrophy (ald) and/or adrenomyeloneuropathy (amn) |
| CN111363756B (zh) * | 2020-04-02 | 2023-01-17 | 中国医学科学院血液病医院(中国医学科学院血液学研究所) | 一种珠蛋白基因双表达慢病毒载体及其应用 |
| BR112022019182A2 (pt) * | 2020-04-06 | 2022-11-29 | Homology Medicines Inc | Composições de vírus adeno-associadas para transferência do gene ids e métodos de uso da mesma |
| EP4323513A4 (en) * | 2021-04-12 | 2025-09-17 | Kamau Therapeutics Inc | METHODS AND COMPOSITIONS FOR THE PRODUCTION OF GENETICALLY MODIFIED PRIMARY CELLS |
| WO2023019185A1 (en) * | 2021-08-10 | 2023-02-16 | Gentibio, Inc. | Compositions and methods for engineering stable tregs |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5449759A (en) * | 1987-05-16 | 1995-09-12 | Somatogen, Inc. | Hemoglobins with intersubunit desulfide bonds |
| US5252479A (en) * | 1991-11-08 | 1993-10-12 | Research Corporation Technologies, Inc. | Safe vector for gene therapy |
| EP0938578B1 (en) * | 1996-12-05 | 2004-02-04 | Crucell Holland B.V. | Genetic modification of primate hemopoietic repopulating stem cells |
| US9725485B2 (en) * | 2012-05-15 | 2017-08-08 | University Of Florida Research Foundation, Inc. | AAV vectors with high transduction efficiency and uses thereof for gene therapy |
| CN101348786B (zh) * | 2007-07-20 | 2011-05-11 | 谭孟群 | 一种人β珠蛋白基因及其重组腺相关病毒载体 |
| WO2009013559A1 (en) * | 2007-07-23 | 2009-01-29 | Cellectis | Meganuclease variants cleaving a dna target sequence from the human hemoglobin beta gene and uses thereof |
| US8628966B2 (en) * | 2010-04-30 | 2014-01-14 | City Of Hope | CD34-derived recombinant adeno-associated vectors for stem cell transduction and systemic therapeutic gene transfer |
| US11242525B2 (en) * | 2014-03-26 | 2022-02-08 | Editas Medicine, Inc. | CRISPR/CAS-related methods and compositions for treating sickle cell disease |
| ES2746529T3 (es) | 2014-09-04 | 2020-03-06 | Memorial Sloan Kettering Cancer Center | Terapia génica de globina para tratar hemoglobinopatías |
| PL3198018T3 (pl) | 2014-09-24 | 2021-07-19 | City Of Hope | Warianty wektora wirusa związanego z adenowirusami dla wysokiej skuteczności edycji genomu i jego sposoby |
| US20180135074A1 (en) * | 2015-02-19 | 2018-05-17 | University Of Florida Research Foundation, Incorporated | Recombinant aav vectors for gene therapy of human hematopoietic disorders |
| AU2017221405A1 (en) * | 2016-02-16 | 2018-09-20 | Carnegie Mellon University | Compositions for enhancing targeted gene editing and methods of use thereof |
-
2018
- 2018-10-17 WO PCT/US2018/056271 patent/WO2019079437A1/en not_active Ceased
- 2018-10-17 CN CN201880079840.8A patent/CN111447954A/zh active Pending
- 2018-10-17 KR KR1020207012240A patent/KR20200095462A/ko not_active Ceased
- 2018-10-17 BR BR112020007765-8A patent/BR112020007765A2/pt unknown
- 2018-10-17 EP EP18804159.4A patent/EP3697450A1/en not_active Withdrawn
- 2018-10-17 JP JP2020542536A patent/JP2021500070A/ja active Pending
- 2018-10-17 US US16/163,061 patent/US12201657B2/en active Active
- 2018-10-17 SG SG11202002737PA patent/SG11202002737PA/en unknown
- 2018-10-17 CA CA3079437A patent/CA3079437A1/en active Pending
- 2018-10-17 AU AU2018352855A patent/AU2018352855B2/en active Active
- 2018-10-17 MX MX2020004092A patent/MX2020004092A/es unknown
-
2020
- 2020-04-07 IL IL273877A patent/IL273877A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11091777B2 (en) | Synthetic combinatorial AAV capsid library for targeted gene therapy | |
| JP2021500070A5 (enExample) | ||
| KR20210103469A (ko) | 재조합 바이러스 벡터 및 이를 생산하기 위한 핵산 | |
| AU2014324717A1 (en) | Synthetic combinatorial AAV capsid library for targeted gene therapy | |
| JP2020054367A (ja) | 改変g6pcをコードするアデノ随伴ウイルスベクターおよびその使用 | |
| EP3133923B1 (en) | Aav-based gene therapy for multiple sclerosis | |
| EP4601612A2 (en) | Nucleic acid regulatory elements for gene expression in the muscle and methods of use | |
| CN111718420A (zh) | 一种用于基因治疗的融合蛋白及其应用 | |
| WO2023202469A1 (zh) | 一种用于遗传性凝血因子缺乏病治疗的核酸构建体及其用途 | |
| WO2016037931A1 (en) | Nucleic acid constructs and expression vectors for gene therapy of acute porphyrias and other diseases | |
| CN115605266A (zh) | Dysferlin双载体的基因疗法 | |
| US20190276856A1 (en) | Adeno-associated virus compositions for restoring f8 gene function and methods of use thereof | |
| WO2022226183A2 (en) | Optimized ap4m1 polynucleotides and expression cassettes and their use | |
| JPWO2019152843A5 (enExample) | ||
| KR102874560B1 (ko) | 아데노연관바이러스 변이체 | |
| US12480098B1 (en) | Adeno-associated virus variant | |
| WO2024094009A1 (zh) | 用于目的基因的表达盒及其应用 | |
| CA2930549C (en) | Synthetic combinatorial aav capsid library for targeted gene therapy | |
| CN117003833A (zh) | 肝脏特异性的腺相关病毒血清型及应用 | |
| HK40041411A (en) | Aav-based gene therapy for multiple sclerosis | |
| HK1234606B (en) | Aav-based gene therapy for multiple sclerosis | |
| HK1234606A1 (en) | Aav-based gene therapy for multiple sclerosis |